CorMedix closes $150M convertible note offering due 2030 at 4.00% interest

CorMedix Inc.

Issued $150M aggregate principal of 4.00% Convertible Senior Notes due 2030 in a private placement.
Initial conversion rate: 74.2515 shares per $1,000 principal (implied conversion price ~$13.47/share).
Notes issued under indenture with U.S. Bank Trust Company; proceeds not specified but likely for corporate purposes.
Sale exempt from registration under Section 4(a)(2) of the Securities Act.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.